Viral Vector and Viral Product Manufacturing Services

ABL is the right strategic partner to enable your life changing innovations. Our 35+ years of process development and GMP production experience accelerates your novel gene therapies, vaccines, oncolytics and immunotherapies to the clinic.

Core expertise in viral-based vaccines, cell & gene therapies, oncolytics, protein subunits and nanoparticle production

Diversity of production platforms across suspension and adherent platforms

Science-driven process development

Closed production systems to minimize risk

Allstream production approach to maximize efficiency and reduce cost

CDMO viral vector, vaccine and gene therapy offering:

Process Development and GMP Production

Large Volume Capacity

Live Virus Aseptic Fill/Finish

Discover ABL's breadth of experience producing viral products for Gene Therapies, Vaccines, Oncolytics and Immunotherapies

Vaccinia and MVA







Lentivirus and other Retroviruses


Comprehensive GMP Manufacturing and Testing Support leverages multiple suites and production platforms to accelerate your journey to the clinic.

Process design

Process feasibility

Upstream and downstream process development

Assay development and qualification

Master and working cell and virus banks

Scale-up and engineering runs

GMP bulk drug substance production

GMP aseptic fill/finish

Analytical lot release testing

ICH stability testing

Chemistry, manufacturing and controls support

ABL is the catalyst for your life-changing, innovative products.

Contact us at